Ligand validation:8C1I

T5L: (1~{R},2~{R})-cyclohexane-1,2-dicarboxylic acid

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8C1I_T5L_A_405	41%	29%	0.229	0.944	1.16	1.65	2	2	0	0	100%	1
8C1D_T5L_A_405	80%	30%	0.094	0.944	1.11	1.67	2	2	0	0	100%	1
8C1F_T5L_A_409	72%	26%	0.108	0.932	1.1	1.85	2	3	0	0	100%	1
8C1K_T5L_A_405	64%	33%	0.161	0.96	1.15	1.5	2	2	0	0	100%	1
8C1G_T5L_A_406	64%	29%	0.108	0.904	1.1	1.7	2	2	0	0	100%	1
8C15_T5L_A_405	43%	30%	0.176	0.901	1.29	1.48	2	2	0	0	100%	1
8C1H_T5L_A_405	43%	30%	0.138	0.859	1.33	1.44	2	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.